BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8236648)

  • 1. Feline bordetellosis: challenge and vaccine studies.
    Jacobs AA; Chalmers WS; Pasman J; van Vugt F; Cuenen LH
    Vet Rec; 1993 Sep; 133(11):260-3. PubMed ID: 8236648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis.
    Williams J; Laris R; Gray AW; Jacobs AA
    Vet Rec; 2002 Apr; 150(14):439-42. PubMed ID: 11993973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
    Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
    J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of Bordetella bronchiseptica in prevention of sneezing disease in two animal shelters].
    Van Houten D
    Tijdschr Diergeneeskd; 2005 Nov; 130(22):699-701. PubMed ID: 16335150
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries.
    Helps CR; Lait P; Damhuis A; Björnehammar U; Bolta D; Brovida C; Chabanne L; Egberink H; Ferrand G; Fontbonne A; Pennisi MG; Gruffydd-Jones T; Gunn-Moore D; Hartmann K; Lutz H; Malandain E; Möstl K; Stengel C; Harbour DA; Graat EA
    Vet Rec; 2005 May; 156(21):669-73. PubMed ID: 15908495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of Bordetella bronchiseptica from cats in southern Louisiana.
    Hoskins JD; Williams J; Roy AF; Peters JC; McDonough P
    Vet Immunol Immunopathol; 1998 Oct; 65(2-4):173-6. PubMed ID: 9839872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
    J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management.
    Egberink H; Addie D; Belák S; Boucraut-Baralon C; Frymus T; Gruffydd-Jones T; Hartmann K; Hosie MJ; Lloret A; Lutz H; Marsilio F; Pennisi MG; Radford AD; Thiry E; Truyen U; Horzinek MC
    J Feline Med Surg; 2009 Jul; 11(7):610-4. PubMed ID: 19481041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on natural transmission of Bordetella bronchiseptica in cats.
    Coutts AJ; Dawson S; Binns S; Hart CA; Gaskell CJ; Gaskell RM
    Vet Microbiol; 1996 Jan; 48(1-2):19-27. PubMed ID: 8701574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against canine bordetellosis: protection from contact challenge.
    McCandlish IA; Thompson H; Wright NG
    Vet Rec; 1978 Jun; 102(22):479-83. PubMed ID: 685092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiological investigation of multiple respiratory infections in cats.
    Di Martino B; Di Francesco CE; Meridiani I; Marsilio F
    New Microbiol; 2007 Oct; 30(4):455-61. PubMed ID: 18080682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs.
    Moore JE; Rendall JC; Millar BC
    J Clin Pharm Ther; 2022 Feb; 47(2):139-145. PubMed ID: 34328230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous Immunization of Dogs With
    Muhammad A; Kassmannhuber J; Rauscher M; Falcon AA; Wheeler DW; Zhang AA; Lubitz P; Lubitz W
    Front Immunol; 2019; 10():1377. PubMed ID: 31293571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of feline herpesvirus-1, feline calicivirus,
    Walter J; Foley P; Yason C; Vanderstichel R; Muckle A
    Can J Vet Res; 2020 Jul; 84(3):181-188. PubMed ID: 32801452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs.
    Ellis JA; Gow SP; Waldner CL; Shields S; Wappel S; Bowers A; Lacoste S; Xu Z; Ball E
    Vet J; 2016 Jun; 212():71-7. PubMed ID: 27256028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella bronchiseptica infections in cats.
    Welsh RD
    J Am Anim Hosp Assoc; 1996; 32(2):153-8. PubMed ID: 8680922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for feline Bordetella bronchiseptica infection.
    Binns SH; Dawson S; Speakman AJ; Cuevas LE; Gaskell CJ; Hart CA; Morgan KL; Gaskell RM
    Vet Rec; 1999 May; 144(21):575-80. PubMed ID: 10378288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.